scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Vista Pharmaceuticals Ltd

Feedback
Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 23,221
Mar 21, 2025 00:00 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹10.75
₹0.21 (-1.92%)
    Powered By :
₹10.75 Low
Today’s Performance
₹11.37 High
₹9.1 Low
52 Week’s Performance
₹16.59 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.92%
  • 1 Week -0.36%
  • 1 Month -0.18%
  • 3 Months -5.84%
  • 6 Months -17.16%
  • 1 Year -7.90%
  • 3 Years 4.15%
  • 5 Years 13.85%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 0.49
  • 52-Week Low (₹) 9.10
  • 52-Week High (₹) 16.59
  • Price-to-Book (X)* 0.97
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* -13.87
  • Earnings Per Share (₹) 0.79
  • Sector Price Earning (X)* 34.01
  • Market Cap (₹ Cr.)* 42.55
  • * Vaues as of last close price

COMPETITORS

BT TV

IndusInd Bank: Expert Explains Why The Stock Could Bounce Back Post-Investigations 2:21 IndusInd Bank: Expert Explains Why The Stock Could Bounce Back Post-Investigations
"Even If We Have To Lose Power For Ram Temple, It’s Not A Problem," Says U.P. CM Yogi Adityanath 2:54 "Even If We Have To Lose Power For Ram Temple, It’s Not A Problem," Says U.P. CM Yogi Adityanath
Rahul Gandhi: India's Merit System Unfair, Dominated by Upper Caste Narrative 1:30 Rahul Gandhi: India's Merit System Unfair, Dominated By Upper Caste Narrative
IPO Market Outlook, Equity Trends, and Private Equity Insights 7:53 IPO Market Outlook, Equity Trends, and Private Equity Insights
Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today 43:37 Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jun 12, 2024 Sell
UMAKANTH KATTA
  • Qty 261188
  • Average Price ₹13.54
Jun 10, 2024 PURCHASE
SUNDARA RAO BEHTA
  • Qty 500000
  • Average Price ₹13.29
Jun 10, 2024 Sell
UMAKANTH KATTA
  • Qty 750979
  • Average Price ₹13.33
Jun 05, 2024 Sell
UMAKANTH KATTA
  • Qty 300103
  • Average Price ₹13.22
Jun 05, 2024 PURCHASE
MEHJABEEN SHALAM
  • Qty 300000
  • Average Price ₹13.22
Dec 28, 2022 Sell
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED
  • Qty 244668
  • Average Price ₹14.41
Dec 28, 2022 PURCHASE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED
  • Qty 183682
  • Average Price ₹13.93
Apr 18, 2022 Sell
NAVEEN MALVAY
  • Qty 201528
  • Average Price ₹8.43
Dec 29, 2021 PURCHASE
SURESH GADALEY
  • Qty 263734
  • Average Price ₹9.33
Sep 13, 2019 PURCHASE
NAVEEN MALVAY
  • Qty 200000
  • Average Price ₹11.30
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Vista Pharmaceuticals Ltd share price previously?
Vista Pharmaceuticals Ltd share price was down by -1.92% from the previous closing price of ₹10.96.
Who are peers of Vista Pharmaceuticals Ltd?
The peers of Vista Pharmaceuticals Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Mankind Pharma Ltd.
Who is/are the promoter/promoters of Vista Pharmaceuticals Ltd?
The promotor/promotors of Vista Pharmaceuticals Ltd are Dhananjaya Alli, M H Rao, Stanley Prabhakar Reddy, Umesh V Banakar, Chakravarthula Divya Bhavani, Umakanth Katta, Divakar Reddy Yerrabommanahalli, Murali Meraga, Pavan Sathvik Gilaka, Barkha Jain, Naga Raja Madineni, Madhu Sudan Anchi, Swapna Priya Gunduboina, Anumala Ravi Chandra Kumar, Rama Mohan Manamasa.
What has been 52-week high of Vista Pharmaceuticals Ltd stocks?
The highest price of Vista Pharmaceuticals Ltd stock is ₹16.59 in the last 52-week.
What is the share price of Vista Pharmaceuticals Ltd () today on BSE?
As on Mar 21, 2025, Vista Pharmaceuticals Ltd ()’s share price on BSE is Rs 10.75
What is the market cap of Vista Pharmaceuticals Ltd (?)
The current market capitalisation of Vista Pharmaceuticals Ltd () is 42.55 crores
What is Vista Pharmaceuticals Ltd Share symbol?
The symbol of Vista Pharmaceuticals Ltd is .
What is the PE ratio of Vista Pharmaceuticals Ltd ()?
The current PE ratio of Vista Pharmaceuticals Ltd () is -13.87.
What is the PB ratio of Vista Pharmaceuticals Ltd ()?
The current PB ratio of Vista Pharmaceuticals Ltd () is 0.97.
Today’s High & Low share prices of Vista Pharmaceuticals Ltd () on BSE?
Today, the share price of Vista Pharmaceuticals Ltd () on BSE touched a high of Rs 11.37 and a low of Rs 10.75
What price did Vista Pharmaceuticals Ltd () shares open on the BSE today?
On BSE, the share price of Vista Pharmaceuticals Ltd () opened at Rs 11.37
What is the 52-week high of Vista Pharmaceuticals Ltd ()?
The 52-week high price of Vista Pharmaceuticals Ltd () is Rs 16.59
What is the 52-week low of Vista Pharmaceuticals Ltd () ?
The 52-week low price of Vista Pharmaceuticals Ltd () is Rs 9.1

ABOUT VISTA PHARMA.

Vista Pharmaceuticals Ltd, incorporated in the year 1991, has its registered office in Plot No 10to14 16to20 APIIC, Industrial Estate Chotyal, Nalgonda, Telangana, 91-09291015956, 91-08682-272551. The main industry in which Vista Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Vista Pharmaceuticals Ltd is/are A M Reddy & D R Reddy. In the main management, Dhananjaya Alli is chairman and Barkha Jain is the company secretary for Vista Pharmaceuticals Ltd.

  • DA Dhananjaya Alli Chairman & Wholetime Director
  • MHR M H Rao Non-Exec & Non-Independent Dir
  • SPR Stanley Prabhakar Reddy Non-Exec & Non-Independent Dir
  • UVB Umesh V Banakar Non-Exec. & Independent Dir.
  • CDB Chakravarthula Divya Bhavani Non-Exec. & Independent Dir.
  • UK Umakanth Katta Non Executive Director
  • DRY Divakar Reddy Yerrabommanahalli Non Executive Director
  • MM Murali Meraga Managing Director
  • PSG Pavan Sathvik Gilaka Whole Time Director
  • BJ Barkha Jain Company Sec. & Compli. Officer
  • NRM Naga Raja Madineni Non-Exec. & Independent Dir.
  • MSA Madhu Sudan Anchi Non-Exec. & Independent Dir.
  • SPG Swapna Priya Gunduboina Non-Exec. & Independent Dir.
  • ARCK Anumala Ravi Chandra Kumar Non-Exec. & Independent Dir.
  • RMM Rama Mohan Manamasa Non-Exec. & Independent Dir.

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement